Identification of potential crucial genes and key pathways in osteosarcoma.

Hereditas

Department of Radiation Oncology, Chongqing University Cancer Hospital, No. 181, Hanyu road, Shapingba District, Chongqing, 400030, PR China.

Published: July 2020

Background: The aim of this study is to identify the potential pathogenic and metastasis-related differentially expressed genes (DEGs) in osteosarcoma through bioinformatic analysis of Gene Expression Omnibus (GEO) database.

Results: Gene expression profiles of GSE14359, GSE16088, and GSE33383, in total 112 osteosarcoma tissue samples and 7 osteoblasts, were analyzed. Seventy-four normal-primary DEGs (NPDEGs) and 764 primary-metastatic DEGs (PMDEGs) were screened. VAMP8, A2M, HLA-DRA, SPARCL1, HLA-DQA1, APOC1 and AQP1 were identified continuously upregulating during the oncogenesis and metastasis of osteosarcoma. The enriched functions and pathways of NPDEGs include procession and presentation of antigens, activation of MHC class II receptors and phagocytosis. The enriched functions and pathways of PMDEGs include mitotic nuclear division, cell adhesion molecules (CAMs) and focal adhesion. With protein-protein interaction (PPI) network analyzed by Molecular Complex Detection (MCODE) plug-in of Cytoscape software, one hub NPDEG (HLA-DRA) and 7 hub PMDEGs (CDK1, CDK20, CCNB1, MTIF2, MRPS7, VEGFA and EGF) were eventually selected, and the most significant pathways in NPDEGs module and PMDEGs module were enriched in the procession and presentation of exogenous peptide antigen via MHC class II and the nuclear division, respectively.

Conclusions: By integrated bioinformatic analysis, numerous DEGs related to osteosarcoma were screened, and the hub DEGs identified in this study are possibly part of the potential biomarkers for osteosarcoma. However, further experimental studies are still necessary to elucidate the biological function and mechanism of these genes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362476PMC
http://dx.doi.org/10.1186/s41065-020-00142-0DOI Listing

Publication Analysis

Top Keywords

degs osteosarcoma
8
bioinformatic analysis
8
gene expression
8
enriched functions
8
functions pathways
8
pathways npdegs
8
procession presentation
8
mhc class
8
nuclear division
8
osteosarcoma
6

Similar Publications

Osteosarcoma is a cancerous bone tumor that develops from mesenchymal cells and is characterized by early metastasis, easy drug resistance, high disability, and mortality. Immunological characteristics of the tumor microenvironment (TME) have attracted attention for the prognosis and treatment of osteosarcoma, and there is a need to explore a signature with high sensitivity for prognosis. In the present study, a total of 84 samples of osteosarcoma were acquired from the UCSC Xena database, analyzed for immune infiltration and classified into two categories depending on their immune properties, and then screened for DEGs between the two groups and analyzed for enrichment, with the majority of DEGs enriched in the immune domain.

View Article and Find Full Text PDF

Background: In China, Tongguanteng injection (TGT) is widely used in the treatment or adjuvant treatment of various types of cancer. However, the effect and mechanism of TGT in osteosarcoma is not clear.

Methods: The 143B and MG-63 cells were treated with different concentrations of TGT.

View Article and Find Full Text PDF
Article Synopsis
  • - The study developed an artificial neural network (ANN) model to predict osteosarcoma (OS) cases based on genetic characteristics, identifying 467 differentially expressed genes (DEGs) with various functions and pathways associated with immune responses and infections.
  • - A PPI network analysis revealed the top ten hub DEGs, and the ANN model was validated for accuracy and reliability in predicting OS based on test samples.
  • - The research also explored the interaction between immune cells and critical DEGs, analyzing the expression of the most significant two DEGs (YES1 and MFNG) in OS compared to normal tissues, highlighting their potential role in early diagnosis and treatment of the disease.
View Article and Find Full Text PDF
Article Synopsis
  • Osteosarcoma is a bone cancer with a poor prognosis, heavily influenced by its tumor microenvironment, prompting research into its metastatic mechanisms for better treatment options.
  • The analysis of various datasets led to the identification of 92 differentially expressed genes related to metastasis, along with several significant pathways involved in the cancer progression.
  • Key findings highlighted 15 hub genes, with Skp2 being crucial for tumor advancement, and an increased presence of CD8+ T cells in metastatic osteosarcoma tissues suggesting immune response involvement.
View Article and Find Full Text PDF

Osteosarcoma (OS) represents the most prevalent malignant bone tumor clinically, significantly impacting the health and safety of patients. The exploration of molecular pathogenic mechanisms is deemed a breakthrough for OS diagnosis and treatment. Within the GSE16088 dataset, a total of 1,948 differentially expressed genes (DEGs) were identified, comprising 1,697 down-regulated and 251 up-regulated genes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!